Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma

Clinical Cancer Research

Volumn 10, Issue 21, 2004, Pages 7347-7356

  Tsuneoka, Makoto ^a   Fujita, Hiromasa ^a   Arima, Nobuyuki ^a   Teye, Kwesi ^a   Okamura, Torahiko ^a   Inutsuka, Hiroki ^a   Koda, Yoshiro ^a   Shirouzu, Kazuo ^a   Kimura, Hiroshi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; RNA; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL PROLIFERATION; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MINA53 GENE; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; TREATMENT OUTCOME;

EID: 8444239640     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0543     Document Type: Article

References (50)

1. Albertson M. Chemoradiotherapy of esophageal cancer. Acta Oncol 2002;41:118-23.
2. Mandard AM, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 2000;462:335-42.
3. Wang DY, Xiang YY, Tanaka M, et al. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China, and its relationship to progression and prognosis. Cancer (Phila) 1994;74:3089-96.
4. Yoshida K, Kawami H, Yamaguchi Y, et al. Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus thymidine kinase gene. Cancer (Phila) 1995;75(Suppl):1467-71.
5. Youssef EM, Matsuda T, Takada N, et al. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer (Phila) 1995;76:358-66.
6. Ikeda G, Isaji S, Das BC, Watanabe M, Kawarada Y. Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer (Phila) 1999;86:1396-405.
7. Fujita H, Hyodo S, Yamana H, Hikita S, Toh Y, Fujii T, Tanaka H, Tou U, Kakegawa T, Inutsuka H. Prognostic factors in esophageal cancer: retrospective evaluation of extended radical lymphadenectomy and adjuvant therapy. In: Peracchia A, Rosati R, Bonavina L, Fumagalli U, Bona S, Chella B, editors. Recent advances in diseases of the esophagus. Bologna, Italy: Monduzzi Editore; 1995. p. 377-83.
8. Coggi G, Bosari S, Roncalli M, et al. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer (Phila) 1997;79:425-32.
9. Kanda Y, Nishiyama Y, Shimada Y, et al. Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines. Int J Cancer 1994;58:291-7.
10. DeRisi J, Penland L, Brown PO, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996;14:457-60.
11. Kihara C, Tsunoda T, Tanaka T, et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 2001;61:6474-9.
12. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array. Clin Cancer Res 2001;7:2213-21.
13. Su H, Hu N, Shih J, et al. Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 2003;63:3872-6.
14. Kan T, Shimada Y, Sato F, et al. Gene expression profiling in human esophageal cancers using cDNA microarray. Biochem Biophys Res Commun 2001;286:792-801.
15. DePinho RA, Schreiber-Agus N, Alt FW. myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 1991;57:1-46.
16. Marcu KB, Bossone SA, Patel AJ. myc function and regulation. Annu Rev Biochem 1992;61:809-60.
17. Morgenbesser SD, DePinho RA. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin Cancer Biol 1994;5:21-36.
18. Henriksson M, Lüscher B. Proteins and the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 1996;68:109-82.
19. Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000;16:653-99.
20. Lüscher B. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene (Amst) 2001;277:1-14.
21. Lutz W, Leon J, Eilers M. Contributions of Myc to tumorigenesis. Biochim Biophys Acta 2002;1602:61-71.
22. Tsuneoka M, Mekada E. Ras/MEK signaling suppresses Myc-dependent apoptosis in cells transformed by c-myc and activated ras. Oncogene 2000;19:115-23.
23. Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999;19:1-11.
24. Tsuneoka M, Nakano F, Ohgusu H, Mekada E. c-myc activates RCC1 gene expression through E-box elements. Oncogene 1997;14:2301-11.
25. Tsuneoka M, Koda Y, Soejima M, Teye K, Kimura H. A novel Myc target gene, mina53, that is involved in cell proliferation. J Biol Chem 2002;277:35450-9.
26. Teye K, Tsuneoka M, Arima N, et al. Increased expression of a Myc target gene mina53 in human colon cancer. Am J Pathol 2004;164:205-16.
27. Nishihira T, Katayama M, Hashimoto Y, Akaishi T. Cell lines from esophageal tumors. San Diego, CA: Academic Press; 1994. p. 269-82.
28. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond) 2001;411:494-8.
29. UICC (International Union Against Cancer). Sobin LH, Wittekind C, editors. TNM classification of malignant tumors, 6th edition. New York: John Wiley & Sons; 2002.
30. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
31. Cox DR. Regression models and life tables. J R Stat Soc Series B 1972;34:187-220.
32. Hozumi M. Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation. Adv Cancer Res 1983;38:121-69.
33. Hickstein DD, Back AL, Collins SJ. Regulation of expression of the CD11b and CD18 subunits of the neutrophil adherence receptor during human myeloid differentiation. J Biol Chem 1989;264:21812-7.
34. Gerdes J, Lemke H, Baish H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. Cancer Res 1984;133:1710-5.
35. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin section. J Pathol 1992;168:357-63.
36. Porschen R, Classen S, Piontek M, Borchard F. Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation. Cancer Res 1994;54:587-91.
37. Opitz OG, Jenkins TD, Rustgi AK. Transcriptional regulation of the differentiation-linked human K4 promoter is dependent upon esophageal-specific nuclear factors. J Biol Chem 1998;273:23912-21.
38. Seery JP, Watt FM. Asymmetric stem-cell divisions define the architecture of human oesophageal epithelium. Curr Biol 2000;10:1447-50.
39. Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol 2001;32:1157-65.
40. Klein U, Tu Y, Stolovizky GA, et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci USA 2003;100:2639-44.
41. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
42. Lopez F, Belloc F, Lacombe F, et al. Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry 1991;12:42-9.
43. Bruno S, Darzynkiewicz Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 1992;25:31-40.
44. Orian A, Steensel BV, Delrow J, et al. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev 2003;17:1101-14.
45. Hurlin PJ, Zhou ZQ, Toyo-Oka K, et al. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J 2003;22:4584-96.
46. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular biology of the cell, 4th edition. New York: Garland Science; 2001. p. 1313-62.
47. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 1992;6:2235-47.
48. Davis AC, Wims M, Spotts GD, Hann SR, Bradley A. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev 1993;7:671-82.
49. Sawai S, Shimono A, Wakamatsu Y, et al. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development (Camb) 1993;117:1445-55.
50. Jain M, Arvanitis C, Chu K, et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science (Wash DC) 2002;297:102-4.